Cefixime Export Market Intelligence: India's 668 Suppliers Shipping to 131 Countries — TransData Nexus 2026

Q: Who are the top cefixime exporters from India?

The top cefixime exporters from India are: 1. MICRO LABS LIMITED — $19.1M (11.0% market share); 2. LUPIN LIMITED — $11.1M (6.4% market share); 3. AUROBINDO PHARMA LTD — $8.0M (4.6% market share); 4. UNIVENTIS MEDICARE LIMITED — $7.6M (4.4% market share); 5. SAKAR HEALTHCARE LIMITED — $7.0M (4.1% market share). Together they account for 30.4% of India's total cefixime export value.

Q: What is the total export value of cefixime from India?

The total export value of cefixime from India is $173.9M USD, recorded across 8,398 shipment transactions from 668 active exporters to 131 destination countries. The average shipment value is $20.7K.

Q: Which countries import cefixime from India?

India exports cefixime to 131 countries worldwide. The top importing countries are: FRANCE (11.3% share, $19.7M), UNITED STATES (7.1% share, $12.3M), PHILIPPINES (6.1% share, $10.5M), AFGHANISTAN (5.9% share, $10.3M), KENYA (5.1% share, $8.8M). These five markets account for 35.5% of total export value.

Q: What is the HS code for cefixime exports from India?

The primary HS code for cefixime exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of cefixime exports from India?

The average unit price for cefixime exports from India is $6.16 USD per unit, with prices ranging from $0.00 to $878.58 depending on formulation, packaging, and order volume. The total market is valued at $173.9M across 8,398 shipments.

Q: Which ports handle cefixime exports from India?

The primary ports for cefixime exports from India are NHAVA SHEVA SEA (INNSA1) (11.0% of shipments), JNPT (5.9% of shipments), JNPT/ NHAVA SHEVA SEA (5.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (5.3% of shipments), SAHAR AIR (4.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of cefixime?

India is one of the world's leading exporters of cefixime due to its large base of 668 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports cefixime to 131 countries, demonstrating 67% global market coverage.

Q: What certifications do Indian cefixime exporters need?

Indian cefixime exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import cefixime from India?

There are 1,805 registered buyers importing cefixime from India, spread across 131 countries. The repeat buyer rate is 62.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top cefixime supplier from India?

MICRO LABS LIMITED is the leading cefixime exporter from India with a market share of 11.0% and total export value of $19.1M across 697 shipments. The top 5 suppliers together control 30.4% of total export value.

Suresh Sormare

Cefixime

India Pharmaceutical Trade Intelligence

$173.9M668 Suppliers131 CountriesHS 30042019

ExportsIndia → FRANCE11.3%India → UNITED STATES7.1%

ImportsUNITED STATES → India$68.6K AUSTRIA → India$16.7K

#1 Supplier: MICRO LABS #1 Buyer: SAAM GROUP

Cefixime Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Cefixime to the World

Between 2022 and 2026, India exported $173.9M worth of cefixime across 8,398 verified shipments to 131 countries — covering 67% of world markets in the Advanced Antibiotics segment. The largest destination is FRANCE (11.3%). MICRO LABS LIMITED leads with a 11.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Cefixime export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Cefixime export data snapshot — $173.9M · 668 exporters · 131 countriesTransData Nexus · Indian Customs Data

Top Cefixime Exporters from India

668 active exporters · Ranked by export value

View all 668 →

Top Cefixime Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MICRO LABS LIMITED	$19.1M	697	25	11.0%
2	LUPIN LIMITED

Top Countries Importing Cefixime from India

131 destination markets · Ranked by import value

All 131 countries →

Top Countries Importing Cefixime from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	FRANCE	$19.7M	11.3%
2	UNITED STATES	$12.3M	7.1%
3	PHILIPPINES	$10.5M	6.1%
4	AFGHANISTAN	$10.3M	5.9%
5	KENYA	$8.8M	5.1%
6	CONGO DR	$8.1M	4.6%
7	MYANMAR	$7.6M	4.4%
8	CAMBODIA	$7.5M	4.3%
9	IRAQ	$6.7M	3.8%
10	VIETNAM	$6.2M	3.6%

FRANCE is India's largest cefixime export destination, absorbing 11.3% of total exports worth $19.7M. The top 5 importing countries — FRANCE, UNITED STATES, PHILIPPINES, AFGHANISTAN, KENYA — together account for 35.5% of India's total cefixime export value. The remaining 126 destination countries collectively receive the other 64.5%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Cefixime to India?

7 origin countries · Total import value: $97.8K

India imports cefixime from 7 countries with a combined import value of $97.8K. The largest supplier is UNITED STATES ($68.6K, 10 shipments), followed by AUSTRIA and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Cefixime to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$68.6K	10	70.1%
2	AUSTRIA	$16.7K	6	17.1%
3	UNITED KINGDOM	$7.5K	2	7.7%
4	ITALY	$2.1K	2	2.1%
5	CANADA	$1.9K	5	1.9%
6	MALTA	$1.0K	8	1.1%
7	SENEGAL	$36	1	0.0%

UNITED STATES is the largest supplier of cefixime to India, accounting for 70.1% of total import value. The top 5 origin countries — UNITED STATES, AUSTRIA, UNITED KINGDOM, ITALY, CANADA — together supply 98.9% of India's cefixime imports. Click any country to see detailed supplier and buyer data for that import corridor.

Cefixime — Export Intelligence Video

Visual overview of India's cefixime import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's cefixime pharmaceutical import and export market — $173.9M in total trade, 668 verified manufacturers, and 131 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Cefixime

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, cefixime is approved for use and is listed in the FDA's Orange Book. The regulatory pathway for cefixime involves the submission of an Abbreviated New Drug Application (ANDA) to the FDA, demonstrating bioequivalence to the reference listed drug. As of March 2026, there are multiple approved ANDAs for cefixime, indicating a competitive market with several generic manufacturers. Notably, Indian exporters have a significant presence in the U.S. market, with 7.1% of India's cefixime exports directed to the United States. This underscores the importance of compliance with FDA regulations, including adherence to Current Good Manufacturing Practices (cGMP) and ensuring product quality to maintain market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), cefixime is subject to stringent regulatory oversight. Marketing authorization requires compliance with the European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) standards. In March 2026, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updating the product information for cefixime to include warnings about potential encephalopathy risks. This decision followed a periodic safety update report (PSUR) assessment, highlighting the need for continuous monitoring and prompt incorporation of safety information into product labeling. Manufacturers exporting to these regions must ensure compliance with EU Good Manufacturing Practice (GMP) guidelines and stay informed about regulatory updates to maintain market authorization.

3WHO Essential Medicines & Global Standards

Cefixime is included in the World Health Organization's (WHO) Model List of Essential Medicines, reflecting its importance in treating bacterial infections. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards ensures the quality, safety, and efficacy of cefixime, facilitating its acceptance in global markets.

4India Regulatory Classification

In India, cefixime is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including cefixime, to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceuticals, ensuring compliance with national regulations and monitoring of drug exports.

5Patent & Exclusivity Status

The primary patents for cefixime have expired, leading to the availability of generic versions and increased competition in the market. This has resulted in a diversified exporter base, with 668 active Indian exporters supplying cefixime to various international markets.

6Recent Industry Developments

In March 2026, the EMA's PRAC recommended updating cefixime's product information to include warnings about potential encephalopathy risks, emphasizing the need for manufacturers to stay vigilant about safety updates. Additionally, in January 2026, the FDA approved a new generic version of cefixime, further intensifying market competition. These developments highlight the dynamic nature of the pharmaceutical industry and the importance of regulatory compliance and market awareness for exporters.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Cefixime

Retail & reference prices across 9 markets vs. India FOB export price of $6.16/unit

Global Price Benchmark for Cefixime across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$3.10	USD	Cefixime is available as a generic medication in the United States.
United Kingdom	$3.25	GBP	Cefixime is listed in the British National Formulary (BNF).
Germany	$3.10	EUR	Cefixime is approved by the European Medicines Agency (EMA).
Australia	$2.80	AUD	Cefixime is listed on the Pharmaceutical Benefits Scheme (PBS).

Supply Chain Risk Assessment — Cefixime

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Cefixime, a third-generation cephalosporin antibiotic, is primarily manufactured in India, which has established itself as a significant producer of Active Pharmaceutical Ingredients (APIs). However, the production of Cefixime heavily relies on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in this sector. This dependency poses a substantial risk, as any disruption in China's supply chain can directly impact the availability and cost of Cefixime APIs.

Recent geopolitical tensions and trade disputes have further highlighted the vulnerabilities associated with this reliance. For instance, in June 2025, the U.S. doubled Section 232 tariffs on steel and aluminum imports, which indirectly affected pharmaceutical supply chains by increasing production costs for equipment and materials. (pharmasource.global) Such events underscore the need for diversification in sourcing strategies to mitigate potential disruptions.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Cefixime account for 30.4% of the total export value, with MICRO LABS LIMITED leading at an 11.0% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could impact global supply chains. To address such vulnerabilities, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic production of critical APIs and reduce dependency on imports. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-APA, marking a significant step towards self-reliance.

Access Complete Cefixime Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 8,398 transactions across 131 markets.

Request Demo View Pricing

Frequently Asked Questions — Cefixime Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top cefixime exporters from India?

The leading cefixime exporters from India are MICRO LABS LIMITED, LUPIN LIMITED, AUROBINDO PHARMA LTD, and 12 others. MICRO LABS LIMITED leads with 11.0% market share ($19.1M). The top 5 suppliers together control 30.4% of total export value.

What is the total export value of cefixime from India?

The total export value of cefixime from India is $173.9M, recorded across 8,398 shipments from 668 active exporters to 131 countries. The average shipment value is $20.7K.

Which countries import cefixime from India?

India exports cefixime to 131 countries. The top importing countries are FRANCE (11.3%), UNITED STATES (7.1%), PHILIPPINES (6.1%), AFGHANISTAN (5.9%), KENYA (5.1%), which together account for 35.5% of total export value.

What is the HS code for cefixime exports from India?

The primary HS code for cefixime exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cefixime

Cefixime

Top Cefixime Exporters from India

Top Countries Importing Cefixime from India

Who Supplies Cefixime to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Cefixime — Export Intelligence Video

Regulatory Landscape — Cefixime

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Cefixime

Supply Chain Risk Assessment — Cefixime

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Cefixime Trade Intelligence

Frequently Asked Questions — Cefixime Exports from India

Who are the top cefixime exporters from India?

What is the total export value of cefixime from India?

Which countries import cefixime from India?

What is the HS code for cefixime exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of cefixime exports from India?

Which ports handle cefixime exports from India?

Why is India a leading exporter of cefixime?

What certifications do Indian cefixime exporters need?

How many buyers import cefixime from India?

What is the market share of the top cefixime exporter from India?

Analysis Methodology